NCT00351273View on ClinicalTrials.gov

Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Arthritis, ReactiveReiter Disease
Interventions
DRUG

Doxycycline and Rifampin

doxycycline 100mg daily; rifampin 300mg daily (both for 6 months)

DRUG

Azithromycin and Rifampin

Azithromycin 500mg daily for 5 days and then twice weekly; Rifampin 300mg daily (both for 6 months)

DRUG

Placebo

Methylcellulose

Trial Locations (3)

33612

University of South Florida, Tampa

70112

Louisiana State University, New Orleans

M5T 2S8

University of Toronto, Toronto

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of South Florida

OTHER

NCT00351273 - Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria | Biotech Hunter | Biotech Hunter